Literature DB >> 21155056

Solitary extrahepatic intraabdominal metastasis from hepatocellular carcinoma after liver transplantation.

Sae Byeol Choi1, Hyungi Kim, Sung Hoon Kim, Young Nyun Park, Kyung Sik Kim.   

Abstract

A liver transplantation is a treatment option in selected patients with hepatocellular carcinoma (HCC). Despite the adequate selection of candidates, recurrences of HCC may still develop. Solitary extrahepatic metastasis from HCC after a liver transplantation is rare. Here we report two cases of HCC demonstrated extrahepatic recurrence to the adrenal gland and spleen, respectively, within one year after a liver transplantation. Since the treatment of solitary extrahepatic metastasis from HCC after a liver transplantation is not standardized, surgical resection was performed. In the case of HCC adrenal metastasis, innumerable intrahepatic metastases were found two months after the adrenalectomy. And 16 months after adrenalectomy, the patient expired due to tumor progression and hepatic failure. In the case of HCC splenic metastasis, postoperative radiation therapy was performed. However, two recurrent HCC nodules were found 15 months after the splenectomy and received transarterial chemoembolization (TACE). And 29 month after the splenectomy, the patient also expired as same causes of former patient.

Entities:  

Mesh:

Year:  2011        PMID: 21155056      PMCID: PMC3017699          DOI: 10.3349/ymj.2011.52.1.199

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  15 in total

1.  Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.

Authors:  Marco Vivarelli; Alessandro Cucchetti; Fabio Piscaglia; Giuliano La Barba; Luigi Bolondi; Antonino Cavallari; Antonio Daniele Pinna
Journal:  Liver Transpl       Date:  2005-05       Impact factor: 5.799

2.  Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Authors:  F Y Yao; L Ferrell; N M Bass; J J Watson; P Bacchetti; A Venook; N L Ascher; J P Roberts
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

Review 3.  Liver transplantation for hepatocellular carcinoma.

Authors:  Myron Schwartz
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

4.  Bilateral adrenal metastases from hepatocellular carcinoma after liver transplantation.

Authors:  Javier F Castroagudín; Arturo González-Quintela; Jorge Martínez; Santiago Tomé; Jerónimo Forteza; Evaristo Varo
Journal:  Hepatogastroenterology       Date:  2002 Jan-Feb

Review 5.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

6.  Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.

Authors:  Rey-Heng Hu; Ming-Chi Ho; Yao-Ming Wu; Seng-Chang Yu; Po-Huang Lee
Journal:  Clin Transplant       Date:  2005-04       Impact factor: 2.863

7.  Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years.

Authors:  T Nakashima; K Okuda; M Kojiro; A Jimi; R Yamaguchi; K Sakamoto; T Ikari
Journal:  Cancer       Date:  1983-03-01       Impact factor: 6.860

8.  Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.

Authors:  B Pérez-Saborido; S Jiménez de los Galanes; J C Menéu-Díaz; C Jiménez Romero; A Moreno Elola-Olaso; Y Fundora Suárez; V Barra Valencia; E Moreno-González
Journal:  Transplant Proc       Date:  2007-09       Impact factor: 1.066

9.  What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma?

Authors:  Joon Seong Park; Dong Sup Yoon; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee; Hoon Sang Chi; Byong Ro Kim
Journal:  J Surg Oncol       Date:  2007-07-01       Impact factor: 3.454

10.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

View more
  4 in total

Review 1.  Recurrent Hepatocellular Carcinoma in the Right Adrenal Gland 11 Years After Liver Transplantation for Hepatocellular Carcinoma: a Case Report and Literature Review.

Authors:  Ismail Cem Sormaz; Gülçin Yegen; Filiz Akyuz; Fatih Tunca; Yasemin Giles Şenyürek
Journal:  Indian J Surg       Date:  2017-08-17       Impact factor: 0.656

2.  Adrenalectomy for solitary recurrent hepatocellular carcinoma five years after living donor liver transplantation: A case report.

Authors:  Mohamed Abdel Wahab; Ahmed Shehta; Eman M Ibrahim; Rehab T Eldesoky; Ahmed A Sultan; Khaled R Zalata; Omar Fathy; Mohamed Elshoubary; Tarek Salah; Amr M Yassen; Mohamed Elmorshedi; Ahmed Monier; Ahmed Farouk; Usama Shiha
Journal:  Int J Surg Case Rep       Date:  2018-11-27

3.  Adrenal Metastasis of Hepatocellular Carcinoma in Patients following Liver Resection or Liver Transplantation: Experience from a Tertiary Referral Center.

Authors:  Eva M Teegen; Martina T Mogl; Johann Pratschke; Nada Rayes
Journal:  Int J Surg Oncol       Date:  2018-07-29

4.  Survival After Adrenalectomy for Metastatic Hepatocellular Carcinoma: A 25-year Institutional Experience.

Authors:  J I Staubitz; M Hoppe-Lotichius; J Baumgart; J Mittler; H Lang; T J Musholt
Journal:  World J Surg       Date:  2020-12-22       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.